Skip to main content
Clinical Trials/NCT04553107
NCT04553107
Completed
Not Applicable

Reducing Healthcare Costs in Older Adults by Deprescribing Unnecessary, Harmful, and Costly Medications

The University of Texas Health Science Center, Houston1 site in 1 country419 target enrollmentDecember 9, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polypharmacy
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
419
Locations
1
Primary Endpoint
Healthcare Cost
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of the study is to implement a pharmacist-led deprescribing intervention for adults 65 and older taking 10 or more medications at University of Texas (UT) Physicians clinics and to assess the effect of the pharmacist intervention on the incidence of adverse drug reactions, emergency room visits, and hospitalizations as well as costs to the patient and to the healthcare system in adults 65 and older taking 10 or more medications treated at UT Physicians.

Registry
clinicaltrials.gov
Start Date
December 9, 2019
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Holly M Holmes

Associate Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • taking 10 or more regular medications

Exclusion Criteria

  • not receiving primary care at UT Physicians

Outcomes

Primary Outcomes

Healthcare Cost

Time Frame: 12 months post enrollment

Healthcare cost based on utilization of clinic visits, emergency room visits, and hospitalizations, based on patient report with specific costs obtained when possible from the Health Information Exchange.

Adverse Drug Reactions

Time Frame: 12 months post enrollment

Patient-reported side effects and adverse events potentially attributable to medication, rated for the likelihood of ADR by an independent reviewer based on the Naranjo algorithm.

Adverse Drug Reactions (ADR)

Time Frame: 3 months post enrollment

Patient-reported side effects and adverse events potentially attributable to medication, rated for the likelihood of ADR by an independent reviewer based on the Naranjo algorithm.

Secondary Outcomes

  • Medication cost(12 months post enrollment)
  • Medication use(At enrollment)
  • QOL(12 months post enrollment)

Study Sites (1)

Loading locations...

Similar Trials